{
  "session_id": "vh_session_sample_upload",
  "total_logs": 6,
  "generated_at": "2024-01-01T10:00:00Z",
  "logs": [
    {
      "log_id": "log_0_root",
      "session_id": "vh_session_sample_upload",
      "timestamp": "2024-01-01T10:00:01Z",
      "level": 0,
      "level_name": "根节点层",
      "agent_id": "root_patient_drug",
      "agent_name": "患者/药物信息",
      "agent_type": "root",
      "phase": "complete",
      "input_data": {
        "original_input": {
          "patient": "65岁，男性，2型糖尿病患者，计划使用二甲双胍500mg治疗",
          "drug": "二甲双胍",
          "disease": "2型糖尿病"
        }
      },
      "output_data": {
        "round1_analysis": "患者基本信息已接收，准备进行药物分析。65岁男性2型糖尿病患者，计划使用二甲双胍500mg进行治疗。",
        "round2_analysis": {
          "llm_analysis": {
            "content": "二甲双胍是治疗2型糖尿病的一线药物，主要通过抑制肝脏葡萄糖生成和改善胰岛素敏感性发挥作用。",
            "confidence": 0.95
          },
          "mcp_analysis": {
            "tool_queries": ["二甲双胍作用机制"],
            "tool_result": "二甲双胍主要作用于肝脏、肌肉和肠道。",
            "raw_tool_results": []
          }
        }
      },
      "analysis_mode": "two_round",
      "activate_next_level": true,
      "execution_time": 2.5,
      "error_message": null
    },
    {
      "log_id": "log_1_organ_liver",
      "session_id": "vh_session_sample_upload",
      "timestamp": "2024-01-01T10:00:03Z",
      "level": 1,
      "level_name": "器官层",
      "agent_id": "organ_liver",
      "agent_name": "肝脏",
      "agent_type": "organ",
      "phase": "complete",
      "input_data": {
        "original_input": {
          "patient": "65岁，男性，2型糖尿病患者，计划使用二甲双胍500mg治疗",
          "drug": "二甲双胍",
          "disease": "2型糖尿病"
        },
        "parent_analysis": {
          "agent_id": "root_patient_drug"
        }
      },
      "output_data": {
        "round1_analysis": "肝脏接收到二甲双胍，开始抑制葡萄糖生成。预计肝脏糖异生降低30-40%。",
        "round2_analysis": {
          "llm_analysis": {
            "content": "肝脏是二甲双胍的主要作用部位之一，通过激活AMPK通路抑制糖异生关键酶。",
            "confidence": 0.92
          },
          "mcp_analysis": {
            "tool_queries": ["二甲双胍对肝脏的影响"],
            "tool_result": "二甲双胍可降低肝脏葡萄糖输出，改善胰岛素抵抗。",
            "raw_tool_results": []
          }
        }
      },
      "analysis_mode": "two_round",
      "activate_next_level": true,
      "execution_time": 1.8,
      "error_message": null
    },
    {
      "log_id": "log_2_tissue_liver_parenchyma",
      "session_id": "vh_session_sample_upload",
      "timestamp": "2024-01-01T10:00:04Z",
      "level": 2,
      "level_name": "组织层",
      "agent_id": "tissue_liver_liver",
      "agent_name": "肝实质组织",
      "agent_type": "tissue",
      "phase": "complete",
      "input_data": {
        "original_input": {
          "patient": "65岁，男性，2型糖尿病患者，计划使用二甲双胍500mg治疗",
          "drug": "二甲双胍",
          "disease": "2型糖尿病"
        },
        "parent_analysis": {
          "agent_id": "organ_liver"
        }
      },
      "output_data": {
        "round1_analysis": "肝实质组织吸收二甲双胍，细胞内药物浓度逐渐升高，AMPK活性增强。",
        "round2_analysis": {
          "llm_analysis": {
            "content": "肝实质细胞内二甲双胍浓度达到有效水平，开始发挥降糖作用。",
            "confidence": 0.88
          },
          "mcp_analysis": {
            "tool_queries": [],
            "tool_result": "",
            "raw_tool_results": []
          }
        }
      },
      "analysis_mode": "two_round",
      "activate_next_level": true,
      "execution_time": 1.2,
      "error_message": null
    },
    {
      "log_id": "log_3_cell_liver",
      "session_id": "vh_session_sample_upload",
      "timestamp": "2024-01-01T10:00:05Z",
      "level": 3,
      "level_name": "细胞层",
      "agent_id": "cell_liver_cell_liver",
      "agent_name": "肝细胞",
      "agent_type": "cell",
      "phase": "complete",
      "input_data": {
        "original_input": {
          "patient": "65岁，男性，2型糖尿病患者，计划使用二甲双胍500mg治疗",
          "drug": "二甲双胍",
          "disease": "2型糖尿病"
        },
        "parent_analysis": {
          "agent_id": "tissue_liver_liver"
        }
      },
      "output_data": {
        "round1_analysis": "肝细胞内二甲双胍通过有机阳离子转运体进入细胞，抑制线粒体复合物I。",
        "round2_analysis": {
          "llm_analysis": {
            "content": "细胞内AMP/ATP比值升高，激活AMPK信号通路。",
            "confidence": 0.90
          },
          "mcp_analysis": {
            "tool_queries": [],
            "tool_result": "",
            "raw_tool_results": []
          }
        }
      },
      "analysis_mode": "two_round",
      "activate_next_level": true,
      "execution_time": 1.5,
      "error_message": null
    },
    {
      "log_id": "log_4_target_ampk",
      "session_id": "vh_session_sample_upload",
      "timestamp": "2024-01-01T10:00:06Z",
      "level": 4,
      "level_name": "靶点层",
      "agent_id": "target_liver_target_ampk",
      "agent_name": "AMPK靶点",
      "agent_type": "target",
      "phase": "complete",
      "input_data": {
        "original_input": {
          "patient": "65岁，男性，2型糖尿病患者，计划使用二甲双胍500mg治疗",
          "drug": "二甲双胍",
          "disease": "2型糖尿病"
        },
        "parent_analysis": {
          "agent_id": "cell_liver_cell_liver"
        }
      },
      "output_data": {
        "round1_analysis": "AMPK被激活，磷酸化下游靶点，抑制糖异生关键酶PEPCK和G6Pase的表达。",
        "round2_analysis": {
          "llm_analysis": {
            "content": "AMPK激活导致肝脏葡萄糖生成显著降低，血糖水平下降。治疗效果良好。",
            "confidence": 0.93
          },
          "mcp_analysis": {
            "tool_queries": ["AMPK在糖代谢中的作用"],
            "tool_result": "AMPK是能量代谢的关键调节因子，激活后抑制糖异生。",
            "raw_tool_results": []
          }
        }
      },
      "analysis_mode": "two_round",
      "activate_next_level": false,
      "execution_time": 1.8,
      "error_message": null
    },
    {
      "log_id": "log_1_organ_gut",
      "session_id": "vh_session_sample_upload",
      "timestamp": "2024-01-01T10:00:07Z",
      "level": 1,
      "level_name": "器官层",
      "agent_id": "organ_gut",
      "agent_name": "肠道",
      "agent_type": "organ",
      "phase": "complete",
      "input_data": {
        "original_input": {
          "patient": "65岁，男性，2型糖尿病患者，计划使用二甲双胍500mg治疗",
          "drug": "二甲双胍",
          "disease": "2型糖尿病"
        },
        "parent_analysis": {
          "agent_id": "root_patient_drug"
        }
      },
      "output_data": {
        "round1_analysis": "肠道吸收二甲双胍，部分在肠道局部发挥作用，增加GLP-1分泌。",
        "round2_analysis": {
          "llm_analysis": {
            "content": "二甲双胍在肠道的局部作用可能占其降糖作用的30%左右。",
            "confidence": 0.85
          },
          "mcp_analysis": {
            "tool_queries": ["二甲双胍对肠道的影响"],
            "tool_result": "二甲双胍可增加肠道GLP-1分泌，改善糖代谢。",
            "raw_tool_results": []
          }
        }
      },
      "analysis_mode": "two_round",
      "activate_next_level": true,
      "execution_time": 1.6,
      "error_message": null
    }
  ]
}

